Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

The agreement will allow Enigma to use its PET imaging tracer PMI04 to visualize microglia activity in neurodegenerative ...

Columnist Ahna Crum relates her years-long struggle with avascular necrosis, the reason she has a "bone to pick" with ...

PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in ...

The Accelerated Cure Project for Multiple Sclerosis launched a new website to better support caregivers of people with MS.

Tech company Century Health will organize and clean Nira Medical's datasets from more than 3,000 people with MS to aid ...

The U.S. Food and Drug Administration (FDA) has added a new boxed warning to the prescribing information for glatiramer acetate, an approved injection therapy for relapsing forms of multiple ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options to help you.

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Columnist Desiree Lama has kept working when her body has called for rest and relaxation. Her new approach is that breaks are ...

TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.